Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1989 Mar 15;258(3):677–682. doi: 10.1042/bj2580677

Regulation of carnitine palmitoyltransferase in vivo by glucagon and insulin.

P S Brady 1, L J Brady 1
PMCID: PMC1138419  PMID: 2543360

Abstract

Carnitine palmitoyltransferase (CPT total) activity and synthesis increase in states where the insulin/glucagon ratio is low, such as starvation and diabetes [Brady & Brady (1987) Biochem. J. 246, 641-646]. However, the effect of glucagon and insulin on CPT synthesis is unknown. The present experiments were designed to determine the effect of glucagon, cAMP [8-(chlorophenylthio) cyclic AMP], and insulin + cAMP on CPT transcription and mRNA amounts over time after injection. The CPT protein that was purified, used to generate antibody, and cloned in these studies was the 68 kDa mitochondrial protein described previously [Brady & Brady (1987) Biochem. J. 246, 641-646; Brady, Feng & Brady (1988) J. Nutr. 118, 1128-1136; Brady & Brady (1989) Diabetes 38, in the press]. Saline-injected control rats exhibited a 2-fold increase in hepatic CPT transcription rate and CPT mRNA over the 5 h experiment from 09:00 to 14:00 h. The effect was most probably due to the fasting state of the rats during the day. Glucagon injection caused an 8-fold increase in transcription rate by 90 min and a 4-fold increase in CPT mRNA by 90-120 min. The cAMP effect had reached a peak by the first time point taken (15 min). Transcription rate was increased 4-fold and CPT mRNA was increased 3-fold at this time. The combination of cAMP + insulin injection did not produce any significant increase in transcription rate or CPT mRNA over the saline-injected controls. CPT mRNA and transcription rate showed a clear dose-response to glucagon injection from 0 to 150 micrograms/100 g body wt. Total CPT activity and immunoreactive CPT were not increased during these experiments. The data indicate that glucagon and insulin interact in control of transcription rate and amount of CPT mRNA, but that increases in CPT immunoreactive protein and activity are temporally delayed. This lag probably relates to the half-life of the CPT protein in vivo, which has been estimated as 2-7 days.

Full text

PDF
677

Images in this article

679Fig. 1.
on p.679

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beale E., Andreone T., Koch S., Granner M., Granner D. Insulin and glucagon regulate cytosolic phosphoenolpyruvate carboxykinase (GTP) mRNA in rat liver. Diabetes. 1984 Apr;33(4):328–332. doi: 10.2337/diab.33.4.328. [DOI] [PubMed] [Google Scholar]
  2. Bieber L. L., Abraham T., Helmrath T. A rapid spectrophotometric assay for carnitine palmitoyltransferase. Anal Biochem. 1972 Dec;50(2):509–518. doi: 10.1016/0003-2697(72)90061-9. [DOI] [PubMed] [Google Scholar]
  3. Boon M. R., Zammit V. A. Use of a selectively permeabilized isolated rat hepatocyte preparation to study changes in the properties of overt carnitine palmitoyltransferase activity in situ. Biochem J. 1988 Feb 1;249(3):645–652. doi: 10.1042/bj2490645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brady L. J., Hoppel C. L., Brady P. S. Hepatic mitochondrial inner-membrane properties, beta-oxidation and carnitine palmitoyltransferases A and B. Effects of genetic obesity and starvation. Biochem J. 1986 Jan 15;233(2):427–433. doi: 10.1042/bj2330427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brady L. J., Silverstein L. J., Hoppel C. L., Brady P. S. Hepatic mitochondrial inner membrane properties and carnitine palmitoyltransferase A and B. Effect of diabetes and starvation. Biochem J. 1985 Dec 1;232(2):445–450. doi: 10.1042/bj2320445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brady P. S., Brady L. J. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase. Biochem J. 1986 Sep 15;238(3):801–809. doi: 10.1042/bj2380801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brady P. S., Brady L. J. Hepatic carnitine palmitoyltransferase turnover and translation rates in fed, starved, streptozotocin-diabetic and diethylhexyl phthalate-treated rats. Biochem J. 1987 Sep 15;246(3):641–649. doi: 10.1042/bj2460641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brady P. S., Dunker A. K., Brady L. J. Characterization of hepatic carnitine palmitoyltransferase. Use of bromoacyl derivatives and antibodies. Biochem J. 1987 Feb 1;241(3):751–757. doi: 10.1042/bj2410751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brady P. S., Feng Y. X., Brady L. J. Transcriptional regulation of carnitine palmitoyltransferase synthesis in riboflavin deficiency in rats. J Nutr. 1988 Sep;118(9):1128–1136. doi: 10.1093/jn/118.9.1128. [DOI] [PubMed] [Google Scholar]
  10. Bremer J. The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoA. Biochim Biophys Acta. 1981 Sep 24;665(3):628–631. doi: 10.1016/0005-2760(81)90282-4. [DOI] [PubMed] [Google Scholar]
  11. Bremer J., Woldegiorgis G., Schalinske K., Shrago E. Carnitine palmitoyltransferase. Activation by palmitoyl-CoA and inactivation by malonyl-CoA. Biochim Biophys Acta. 1985 Jan 9;833(1):9–16. doi: 10.1016/0005-2760(85)90247-4. [DOI] [PubMed] [Google Scholar]
  12. Clarke P. R., Bieber L. L. Isolation and purification of mitochondrial carnitine octanoyltransferase activities from beef heart. J Biol Chem. 1981 Oct 10;256(19):9861–9868. [PubMed] [Google Scholar]
  13. Declercq P. E., Falck J. R., Kuwajima M., Tyminski H., Foster D. W., McGarry J. D. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. J Biol Chem. 1987 Jul 15;262(20):9812–9821. [PubMed] [Google Scholar]
  14. Gamble M. S., Cook G. A. Alteration of the apparent Ki of carnitine palmitoyltransferase for malonyl-CoA by the diabetic state and reversal by insulin. J Biol Chem. 1985 Aug 15;260(17):9516–9519. [PubMed] [Google Scholar]
  15. Grantham B. D., Zammit V. A. Role of carnitine palmitoyltransferase I in the regulation of hepatic ketogenesis during the onset and reversal of chronic diabetes. Biochem J. 1988 Jan 15;249(2):409–414. doi: 10.1042/bj2490409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Grantham B. D., Zammit V. A. Studies on the activation in vitro of carnitine palmitoyltransferase I in liver mitochondria from normal, diabetic and glucagon-treated rats. Biochem J. 1987 Apr 1;243(1):261–265. doi: 10.1042/bj2430261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Harano Y., Kashiwagi A., Kojima H., Suzuki M., Hashimoto T., Shigeta Y. Phosphorylation of carnitine palmitoyltransferase and activation by glucagon in isolated rat hepatocytes. FEBS Lett. 1985 Sep 2;188(2):267–272. doi: 10.1016/0014-5793(85)80385-9. [DOI] [PubMed] [Google Scholar]
  18. Harano Y., Kosugi K., Kashiwagi A., Nakano T., Hidaka H., Shigeta Y. Regulatory mechanism of ketogenesis by glucagon and insulin in isolated and cultured hepatocytes. J Biochem. 1982 May;91(5):1739–1748. doi: 10.1093/oxfordjournals.jbchem.a133866. [DOI] [PubMed] [Google Scholar]
  19. Harano Y., Kowal J., Yamazaki R., Lavine L., Miller M. Carnitine palmitoyltransferase activities (1 and 2) and the rate of palmitate oxidation in liver mitochondria from diabetic rats. Arch Biochem Biophys. 1972 Dec;153(2):426–437. doi: 10.1016/0003-9861(72)90360-8. [DOI] [PubMed] [Google Scholar]
  20. Hoppel C. L., Tomec R. J. Carnitine palmityltransferase. Location of two enzymatic activities in rat liver mitochondria. J Biol Chem. 1972 Feb 10;247(3):832–841. [PubMed] [Google Scholar]
  21. Hoppel C., DiMarco J. P., Tandler B. Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. J Biol Chem. 1979 May 25;254(10):4164–4170. [PubMed] [Google Scholar]
  22. McGarry J. D., Foster D. W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. 1980;49:395–420. doi: 10.1146/annurev.bi.49.070180.002143. [DOI] [PubMed] [Google Scholar]
  23. Miyazawa S., Ozasa H., Osumi T., Hashimoto T. Purification and properties of carnitine octanoyltransferase and carnitine palmitoyltransferase from rat liver. J Biochem. 1983 Aug;94(2):529–542. doi: 10.1093/oxfordjournals.jbchem.a134384. [DOI] [PubMed] [Google Scholar]
  24. Morris S. M., Jr, Moncman C. L., Rand K. D., Dizikes G. J., Cederbaum S. D., O'Brien W. E. Regulation of mRNA levels for five urea cycle enzymes in rat liver by diet, cyclic AMP, and glucocorticoids. Arch Biochem Biophys. 1987 Jul;256(1):343–353. doi: 10.1016/0003-9861(87)90455-3. [DOI] [PubMed] [Google Scholar]
  25. Murthy M. S., Pande S. V. Some differences in the properties of carnitine palmitoyltransferase activities of the mitochondrial outer and inner membranes. Biochem J. 1987 Dec 15;248(3):727–733. doi: 10.1042/bj2480727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nosadini R., Ursini F., Tessari P., Giengo A., Gregolin C. Perfused liver carnitine palmitoyl-transferase activity and ketogenesis in streptozotocin treated and genetic hyperinsulinemic rats. Effect of glucagon. Horm Metab Res. 1979 Dec;11(12):661–664. doi: 10.1055/s-0028-1092794. [DOI] [PubMed] [Google Scholar]
  27. Ozasa H., Miyazawa S., Osumi T. Biosynthesis of carnitine octanoyltransferase and carnitine palmitoyltransferase. J Biochem. 1983 Aug;94(2):543–549. doi: 10.1093/oxfordjournals.jbchem.a134385. [DOI] [PubMed] [Google Scholar]
  28. Pande S. V., Murthy M. S., Noël H. Differential effects of phosphatidylcholine and cardiolipin on carnitine palmitoyltransferase activity. Biochim Biophys Acta. 1986 Jun 27;877(2):223–230. doi: 10.1016/0005-2760(86)90298-5. [DOI] [PubMed] [Google Scholar]
  29. Ramsay R. R., Derrick J. P., Friend A. S., Tubbs P. K. Purification and properties of the soluble carnitine palmitoyltransferase from bovine liver mitochondria. Biochem J. 1987 Jun 1;244(2):271–278. doi: 10.1042/bj2440271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ramsay R. R. The soluble carnitine palmitoyltransferase from bovine liver. A comparison with the enzymes from peroxisomes and from the mitochondrial inner membrane. Biochem J. 1988 Jan 1;249(1):239–245. doi: 10.1042/bj2490239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rucker R., Tinker D. The role of nutrition in gene expression: a fertile field for the application of molecular biology. J Nutr. 1986 Feb;116(2):177–189. doi: 10.1093/jn/116.2.177. [DOI] [PubMed] [Google Scholar]
  32. Saggerson E. D., Carpenter C. A. Effects of fasting, adrenalectomy and streptozotocin-diabetes on sensitivity of hepatic carnitine acyltransferase to malonyl CoA. FEBS Lett. 1981 Jul 6;129(2):225–228. doi: 10.1016/0014-5793(81)80170-6. [DOI] [PubMed] [Google Scholar]
  33. Woeltje K. F., Kuwajima M., Foster D. W., McGarry J. D. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. II. Use of detergents and antibodies. J Biol Chem. 1987 Jul 15;262(20):9822–9827. [PubMed] [Google Scholar]
  34. Woldegiorgis G., Bremer J., Shrago E. Substrate inhibition of carnitine palmitoyltransferase by palmitoyl-CoA and activation by phospholipids and proteins. Biochim Biophys Acta. 1985 Nov 14;837(2):135–140. doi: 10.1016/0005-2760(85)90236-x. [DOI] [PubMed] [Google Scholar]
  35. Wynshaw-Boris A. J., Hanson R. W. Approaches to the study of hormonal regulation of gene expression. Horiz Biochem Biophys. 1983;7:171–203. [PubMed] [Google Scholar]
  36. Zammit V. A., Corstorphine C. G., Kelliher M. G. Evidence for distinct functional molecular sizes of carnitine palmitoyltransferases I and II in rat liver mitochondria. Biochem J. 1988 Mar 1;250(2):415–420. doi: 10.1042/bj2500415. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES